Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 2.16 M2.32 M2.41 M71 K1.4 M 6.2 M Research & development ————— — Operating income 9.06 M9.21 M9.8 M-2.32 M10.26 M 26.94 M Non-Operating Income, Total -119 K140 K349 K962 K972 K 2.42 M Interest expense, net of interest capitalized 4.12 M4.35 M4.67 M4.67 M4.56 M 18.25 M Non-Operating Income, excl. Interest Expenses -4.24 M-4.21 M-4.32 M-3.71 M-3.59 M -15.82 M Unusual income/expense ————— — Pretax income 878 K1.1 M1.34 M662 K613 K 3.71 M Equity in earnings ————— — Taxes 173 K219 K256 K46 K119 K 640 K Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 705 K879 K1.08 M-1.41 M494 K 1.04 M Discontinued operations ————-375 K — Net income 705 K879 K1.08 M-1.41 M119 K 667 K Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 705 K879 K1.08 M-1.41 M119 K 667 K Basic earnings per share (Basic EPS) 0.040.050.06-0.080.01 0.04 Diluted earnings per share (Diluted EPS) 0.040.050.06-0.080.01 0.04 Average basic shares outstanding 18.31 M18.33 M18.35 M18.2 M16.28 M — Diluted shares outstanding 18.31 M18.33 M18.35 M18.2 M16.29 M — EBITDA 9.34 M9.58 M10.03 M-6.55 M6.05 M 19.12 M EBIT 8.71 M8.87 M9.36 M-7.3 M5.37 M 16.3 M Cost of revenue 6.34 M6.83 M6.95 M1.02 M1.09 M 15.89 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 636 K711 K677 K754 K685 K 2.83 M